Literature DB >> 18458911

Staging of extrahepatic cholangiocarcinoma.

Yong Eun Chung1, Myeong-Jin Kim, Young Nyun Park, Yoon-Hee Lee, Jin-Young Choi.   

Abstract

Preoperative staging of extrahepatic cholangiocarcinoma is important in determining the best treatment plan. Several classification systems have been suggested to determine the operability and extent of surgery. Longitudinal tumor extent is especially important in extrahepatic cholangiocarcinoma because operative methods differ depending on the tumor extent. The Bismuth-Corlette classification system provides useful information when planning for surgery. However, this classification system is not adequate for selecting surgical candidates. Anatomic variation of the bile duct and gross morphology of the tumor must be considered simultaneously. Lateral spread of the tumor can be evaluated based on the TNM staging provided by American Joint Committee on Cancer (AJCC). However, there is a potential for ambiguity in the distinction of T1 and T2 cancer from one another. In addition, T stage does not necessarily mean invasiveness. Blumgart T staging is helpful for the assessment of resectability with the consideration of nodal status and distant metastasis as suggested by the AJCC cancer staging system. Computed tomography (CT) and magnetic resonance imaging (MRI) are the primary tools used in the assessment of longitudinal and lateral spread of a tumor when determining respectability. Diagnostic laparoscopy and positron emission tomography (PET) may play additional roles in this regard.

Entities:  

Mesh:

Year:  2008        PMID: 18458911     DOI: 10.1007/s00330-008-1006-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  42 in total

1.  Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma.

Authors:  Seung-Mo Hong; Alison E Presley; Edward B Stelow; Henry F Frierson; Christopher A Moskaluk
Journal:  Am J Surg Pathol       Date:  2006-06       Impact factor: 6.394

2.  Hepatectomy for peripheral cholangiocarcinoma in elderly patients.

Authors:  Chun-Nan Yeh; Yi-Yin Jan; Miin-Fu Chen
Journal:  Ann Surg Oncol       Date:  2006-09-29       Impact factor: 5.344

3.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

4.  Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

Authors:  Takashi Kato; Eriko Tsukamoto; Yuji Kuge; Chietsugu Katoh; Toshikazu Nambu; Aichiro Nobuta; Satoshi Kondo; Masahiro Asaka; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-01       Impact factor: 9.236

5.  Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.

Authors:  Takanori Yoshida; Toshifumi Matsumoto; Atsushi Sasaki; Kohei Shibata; Masanori Aramaki; Seigo Kitano
Journal:  Am J Surg       Date:  2004-06       Impact factor: 2.565

6.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

7.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

Review 8.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

9.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

Authors:  Christopher D Anderson; Michael H Rice; C Wright Pinson; William C Chapman; Ravi S Chari; Dominique Delbeke
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

10.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

View more
  11 in total

1.  UICC-TNM and JSBS staging systems with extrahepatic cholangiocarcinoma.

Authors:  Viroj Wiwanitkit
Journal:  Langenbecks Arch Surg       Date:  2010-06-03       Impact factor: 3.445

Review 2.  Imaging of Cholangiocarcinoma.

Authors:  Susann-Cathrin Olthof; Ahmed Othman; Stephan Clasen; Christina Schraml; Konstantin Nikolaou; Malte Bongers
Journal:  Visc Med       Date:  2016-12-06

3.  Peribiliary liver metastases MR findings.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Maddalena Leongito; Francesco Izzo; Antonella Petrillo
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.064

Review 4.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

5.  Percutaneous "Y" biliary stent placement in palliative treatment of type 4 malignant hilar stricture.

Authors:  Fabio Corvino; Luca Centore; Emilio Soreca; Antonio Corvino; Vincenzo Farbo; Alfonso Bencivenga
Journal:  J Gastrointest Oncol       Date:  2016-04

6.  Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum.

Authors:  Mangal S Mahajan; Srikanth Moorthy; Sreekumar P Karumathil; R Rajeshkannan; Ramchandran Pothera
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

7.  Magnetic resonance cholangiographic evaluation of intrahepatic and extrahepatic bile duct variations.

Authors:  Binit Sureka; Kalpana Bansal; Yashwant Patidar; Ankur Arora
Journal:  Indian J Radiol Imaging       Date:  2016 Jan-Mar

8.  Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Raffaele Palaia; Gerardo Botti; Fabiana Tatangelo; Francesco Granata; Marco Cascella; Francesco Izzo; Antonella Petrillo
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

Review 9.  Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology.

Authors:  Dong Ho Lee; Bohyun Kim; Eun Sun Lee; Hyoung Jung Kim; Ji Hye Min; Jeong Min Lee; Moon Hyung Choi; Nieun Seo; Sang Hyun Choi; Seong Hyun Kim; Seung Soo Lee; Yang Shin Park; Yong Eun Chung
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

10.  Comparing percutaneous primary and secondary biliary stenting for malignant biliary obstruction: A retrospective clinical analysis.

Authors:  Nikolaos Chatzis; Roger Pfiffner; Michael Glenck; Paul Stolzmann; Thomas Pfammatter; Pankaj Sharma
Journal:  Indian J Radiol Imaging       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.